The firm managed a Price-to-Book ratio of 0.69, which equates the market value of a stock with its book value.Release Date: JThis is the sixth maintenance release of Python 3.9 The stock has achieved an effective Price-to-Sales Ratio of 0.78 that mirrors the cost to be found for sales by the market. Forward price-to-earnings is calculated using predicted earnings for the next financial year’s P/E determination. The price-to-earnings ratio for Angiodynamic Inc (NASDAQ:ANGO) is 42.94. Market capitalization is the total value of all outstanding shares of a corporation and it is used to measure a company’s market value. The stock’s market cap achieved a total value of $261.81 million as of the last trading session. The higher the number, the more profits are generated for the company and vice versa. The profit margin, also known as the revenue ratio or gross profit ratio, is an efficiency figure used to estimate the business’s profitability by comparing net income and sales. With regard to the profitability of the company, the operating margin is currently at -6.22 percent and the profit margin is 1.92 percent, and the company has reported a gross margin of 45.97 percent. What Does Angiodynamic Inc’s Profitability and Valuation Ratios Tell Us About the Stock? ANGO stock is trading at a margin of -8.85%, -14.93% and -35.36% apart from the 20-Day, 50-Day and 200-Day Simple Moving Average prices. Despite the fact that the share price decreased -27.72% in the last 6 months and -31.28% was subtracted to its value over the previous 3 months. The firm’s stock price fluctuated -7.07% within the last five trades and -12.05% within the last 30 trades, which was a significant change from the beginning of this year. The stock price fluctuated between $6.36 and $6.62 throughout the trading session with the volume trading being 662185 shares, which represented a significant variation when compared to the three months average volume of 706.10K shares. The share price of Angiodynamic Inc (NASDAQ:ANGO) raised 2.50% to close Friday’s market session at $6.57, higher as compared to yesterday’s close.

The latest trade, Performances and Moving Averages give us the following Picture The rating was released on September 25, 2023, according to finviz.

Wainwright raised the price target for the Angiodynamic Inc (NASDAQ:ANGO) stock to “a Buy”.

CHK Rus 3.96 for ios instal